This HTML5 document contains 126 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://dx.doi.org/10.1177/
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q36135142

rdf:type

wikibase:Item

schema:description

2005년 논문 2005年论文 مقالهٔ علمی 2005年論文 2005年论文 article scientifique (publié 2005) наукова стаття, опублікована в травні 2005 vedecký článok 2005年論文 vitskapeleg artikkel artigo científico wissenschaftlicher Artikel naučni članak سائنسی مضمون научна статия article científic artikull shkencor artykuł naukowy artigo científico (publicado na 2005) vetenskaplig artikel επιστημονικό άρθρο գիտական հոդված мақолаи илмӣ 2005年の論文 2005年論文 articolo scientifico artículu científicu espublizáu en 2005 bilimsel makale tieteellinen artikkeli מאמר מדעי სამეცნიერო სტატია teaduslik artikkel artigo científico (publicado na 2005) article scientific บทความทางวิทยาศาสตร์ videnskabelig artikel (udgivet 2005) مقالة علمية نشرت في مايو 2005 artículo científico publicado en 2005 2005年论文 научная статья artikulong pang-agham мақолаи илмӣ tudományos cikk 2005年論文 vědecký článek wetenschappelijk artikel 2005年论文 scienca artikolo scientific article articol științific 2005年论文 научни чланак bài báo khoa học научни чланак 2005 nî lūn-bûn vitenskapelig artikkel 2005年論文 2005年论文 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ mokslinis straipsnis

p:P577

wds:Q36135142-CE742D47-1932-4A4C-92BA-3D508FD15105

wdt:P577

2005-05-01T00:00:00Z

p:P2860

wds:Q36135142-DC94C132-B5C8-4C74-898E-2CC34DB3C30C wds:Q36135142-B660C0DA-D837-4026-8F9D-1A8908BC3BF8 wds:Q36135142-CABD5BDC-949F-488E-B66E-082599839C6D wds:Q36135142-4F4C88D9-AFF4-40E9-96A5-F2B4FECE0407 wds:Q36135142-60A3B93B-B1C7-4399-B690-9869830F9F0F wds:Q36135142-35AB8363-2E47-429D-BA52-4A9234B04E14 wds:Q36135142-3F7258DA-E442-49AB-896E-EBB19F1E2302 wds:Q36135142-A23010F0-5DC9-4F1C-A33A-95C1DBF2E526 wds:Q36135142-A4739C74-1EAF-4435-9E5B-3FE1607C2711 wds:Q36135142-656D6A3F-BE21-4E34-ADE6-0FF11C7E4927 wds:Q36135142-111E1A07-9DC7-4A90-A878-0325C79D4691

wdt:P2860

wd:Q40468790 wd:Q39441138 wd:Q39449130 wd:Q39444283 wd:Q35752351 wd:Q39415383 wd:Q44541854 wd:Q51529896 wd:Q40115663 wd:Q32147934 wd:Q33435886

p:P2093

wds:Q36135142-5362315A-7C46-4E38-B500-81DA58B3ECFB wds:Q36135142-90F66CF4-54BD-4E8F-8C50-9AE3A4FC1828 wds:Q36135142-9948C415-A496-49C5-A1AE-39E1998D909C wds:Q36135142-D1DBC144-6CEF-46FD-9E41-55F26715604F

wdt:P2093

Marinos L Tsiatas Lambros Vlahos Efi Parpa Emmanuela Katsouda

rdfs:label

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

skos:prefLabel

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

schema:name

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics

p:P50

wds:Q36135142-9A4D4A41-4788-4F65-9987-AF681E18637C

wdt:P50

wd:Q90242157

p:P1476

wds:Q36135142-E4EE6EAE-1676-47D8-9DFA-98404FFF883D

wdt:P1476

Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

p:P304

wds:Q36135142-2673EA49-0C59-4A65-86DD-EA806BAD2450

wdt:P304

228-232

p:P31

wds:Q36135142-FE347C5D-0855-4770-A380-EA70E9176991 wds:Q36135142-a27f4612-ed3b-4b6b-a910-3b9aa54a499d

wdt:P31

wd:Q7318358 wd:Q13442814

p:P921

wds:Q36135142-B6D68999-7E3B-4311-9CA3-03585FDACBBB

wdt:P921

wd:Q407541

p:P698

wds:Q36135142-BF102F38-2B74-4BE9-B158-6FD2504EDC79

wdtn:P698

n12:15909786

wdt:P698

15909786

p:P1433

wds:Q36135142-265F05BA-9AC5-4DEE-AC0D-761728440CB1

wdt:P1433

wd:Q4744247

p:P433

wds:Q36135142-61B5A085-A4A3-4B3C-8550-8408637CAA7B

p:P478

wds:Q36135142-4DB6C3C9-3BF8-484A-BFC3-FD367E71BDEA

wdt:P433

3

wdt:P478

22

p:P356

wds:Q36135142-95A2BAAD-AE63-4F24-AE1D-8B5CF594FE8F

wdtn:P356

n9:104990910502200313

wdt:P356

10.1177/104990910502200313